Clinical trials

Condition   Drug Name  
Study Voclosporin in psoriasis
Design Randomized; Double-blind
Patients 451
Treatment Regimen Voclosporin, 0.2 mg/kg b.i.d. x 24 wks --> 0.3 mg/kg b.i.d. x 36 wks; Voclosporin, 0.3 mg/kg b.i.d. x 60 wks; Voclosporin, 0.4 mg/kg b.i.d. x 24 wks --> 0.3 mg/kg b.i.d. x 36 wks; Placebo x 12 wks --> Voclosporin, 0.3 mg/kg b.i.d. x 48 wks
Conclusions Plaque psoriasis patients treated with voclosporin had a low incidence of psoriatic flare and return of disease after discontinuing thearpy
Reference(s) ISA247: Low rates of psoriatic flare or recurrence of disease after discontinuation of therapy
16th Congr Eur Acad Dermatol Venereol (EADV) (May 16 2007 , Vienna) 2007:Abst P207.
Author and Affiliation Tomi, Z., Poulin, Y., Carey, W., et al.